about
GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cellsSec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cellsClassical Flt3L-dependent dendritic cells control immunity to protein vaccineFlt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain.Circulating precursors of human CD1c+ and CD141+ dendritic cells.Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers.Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell FormationType I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.Flt3L dependence helps define an uncharacterized subset of murine cutaneous dendritic cellsBrain dendritic cells: biology and pathology.IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and toleranceThe origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.Langerhans Cells Orchestrate TFH-Dependent Humoral Immunity.PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSFIntegrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signatureDocosahexaenoic Acid alleviates atopic dermatitis in mice by generating T regulatory cells and m2 macrophagesTOX is a critical regulator of tumour-specific T cell differentiation
P50
Q28155998-B128B33B-4C4A-4292-A5BF-BC807C6BFFCEQ28273946-CF1B43FB-7A76-4221-9BFA-440E1396FC3CQ34089167-CA053D34-A4F9-454F-8828-107632B7427EQ35144558-3780B3AB-E6D8-4CC6-B8CD-319B24B89202Q35161496-CD7BA611-3B69-46EF-9408-BE578287B786Q35579455-5548445C-0C19-413B-930C-A2346C1617DCQ35939888-D890EE07-CF51-4238-9B9C-23CFF1B2503FQ36093861-BACA8BC7-EDE7-4358-A1C0-74BEBC360FD7Q36984429-C21F7804-8961-43B6-97FA-945C558A1A7FQ37715466-1D54CFE7-BDEC-4D27-A9DA-DA9354DF1F43Q38028845-1B83A08B-DE2E-4A10-A2F8-90ADFC551835Q38699928-8B6BE733-1389-4643-A00F-D67ECDDD2314Q38719738-6EC12879-6108-4380-8781-76696AB44AF2Q39020369-501987AC-9149-4639-8B3F-88EA95517110Q40134053-FCDD71AA-F7ED-4B25-A288-3E49630FD440Q50564874-B7D004B0-54E9-49E1-A8F9-174A74C6653EQ57450903-23A3A20B-3F1F-42F9-B070-2FF4DE180CB0Q59126379-04ABBEA6-F6D6-4D0C-AC8F-D64319517E9BQ87289913-8C86A348-A3CA-4427-B632-AA6405713987Q92812691-CE9304D3-74FD-41E6-AF4E-44FD6BB6DFD2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Niroshana Anandasabapathy
@ast
Niroshana Anandasabapathy
@en
Niroshana Anandasabapathy
@es
Niroshana Anandasabapathy
@nl
type
label
Niroshana Anandasabapathy
@ast
Niroshana Anandasabapathy
@en
Niroshana Anandasabapathy
@es
Niroshana Anandasabapathy
@nl
prefLabel
Niroshana Anandasabapathy
@ast
Niroshana Anandasabapathy
@en
Niroshana Anandasabapathy
@es
Niroshana Anandasabapathy
@nl
P106
P1153
24333919700
P31
P496
0000-0002-0473-8358